Navigation Links
Breastfeeding boost IQ in infants with 'helpful' genetic variant
Date:11/5/2007

New Haven, Conn.Breastfeeding boosts infants IQs, but only if the babies have a genetic variant that enhances their metabolism of breast milk, a Yale researcher and collaborators report today in Proceedings of the National Academy of Sciences.

It is this genetic variant in FADS2, a gene involved in the control of fatty acid pathways, that may help the children make better use of the breast milk and promote the brain development that is associated with a higher IQ score, said Julia Kim-Cohen, assistant professor of psychology and a member of the research team.

Children who do not carry the helpful genetic variant have normal average IQ scores, Kim-Cohen said. Being breastfed for them is not associated with an IQ advantage.

The study included researchers from Kings College, London, Duke University, and the University of Otago in Dunedin, New Zealand.

The intelligence quotient (IQ) has long been at the heart of debates about nature versus nurture. Twin studies document both strong genetic influences and nongenetic environmental influences on IQ, particularly for young children.

This study looked at how long-chain polyunsaturated fatty acids (LC-PUFAS), which are present in human milk but not in cows milk or most infant formulas, are metabolized. LC-PUFAS in breast milk, the authors said, is believed to enhance cognitive development because the fatty acids are required for efficient neurotransmission and are involved in neuronal growth and regeneration.

The study included 1,037 children in New Zealand and 1,116 families with same sex twins in England and Wales. Those who were breastfed and had the genetic variant FADS2 had IQs that were 5.6 to 6.3 points higher than children who were breastfed but did not have the variant.

The finding has many implications, including for the public understanding of genetics, the authors said. To date, research on gene-environment interactions has been dominated by the search for genetic variants that increase disease susceptibility to environmental pathogens. However, genes are not only implicated in disease. Here we have shown that a genetic variant may also enhance a favorable response to a health promoting exposure present throughout human ancestry.


'/>"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
Source:Eurekalert

Related biology news :

1. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
2. Rutgers high school outreach gets $3 million boost from NSF
3. Breast cancer research and inkjet tissue printing get NSF boost
4. Monkeys use baby talk to interact with infants
5. Soy isoflavone may inhibit common gastrointestinal illness in infants
6. Does the desire to consume alcohol and tobacco come from our genetic makeup?
7. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
8. Many parents at-risk for cancer disclose genetic test results to children
9. Genetics determine optimal drug dose of common anticoagulant
10. Claims of sex-related differences in genetic association studies often not properly validated
11. American College of Medical Genetics responds to new FDA labeling decision for warfarin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2016)... Minn. , Jan. 20, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... 2015. MedNet,s significant achievements are the result of the ... iMedNet eClinical , it,s comprehensive, easy-to-use ... --> --> Key MedNet growth achievements ...
(Date:1/13/2016)... --> --> ... report titled - Biometric Sensors Market - Global Industry Analysis, ... to the report, the global biometric sensors market was valued at ... US$1,625.8 mn by 2023, expanding at a CAGR of ... the biometric sensors market is expected to reach 1,799.6 ...
(Date:1/8/2016)... MANCHESTER, United Kingdom , Jan. 8, 2016   ... diagnostic products, today announced the closing of a $9 million ... Proceeds from the financing will be used to accelerate the ... for detecting early-stage pressure ulcers. United ... receiving CE Mark approval. The device,s introduction has been met ...
Breaking Biology News(10 mins):
(Date:2/9/2016)... 9, 2016 DelveInsight,s, ... report provides in depth insights on the ... the Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors. The ... various stages of development including Discovery, Pre-clinical, ... and Preregistration. Report covers the product clinical ...
(Date:2/8/2016)... 8, 2016 Should antibiotic bone cement products ... to prevent infection after standard total hip or knee ... ECRI Institute have been fielding a lot lately. ... Bottom Line?" --> "Antibiotic Bone ... --> While there isn,t a simple ...
(Date:2/8/2016)... 2016 --> ... innovation-driven oncology company developing next generation cancer therapeutics ... announced that chairman emeritus of Tata Sons Limited, ... company as part of the first close of ... Navam Capital and Aarin Capital. http://photos.prnewswire.com/prnh/20150923/766442 ...
(Date:2/8/2016)... ... February 08, 2016 , ... Thomas J. Todorow has joined ... President for Corporate Services and the Chief Financial Officer at The Children’s Hospital ... Treasury, Managed Care Contracting, Supply Chain, and Investments. , Prior to joining CHOP ...
Breaking Biology Technology: